3 Investment Trends Shaping Behavioral Health Deals in 2026

Bypaulgruensfelder June 10, 2026July 18, 2026

Behavioral Health Business June 3, 2026

AI-Generated Summary

Behavioral health M&A in 2026 is running slower than expected but deal activity continues. SUD treatment may be the most undervalued subsector, with deal flow at a six-year low yet clinically strong operators attracting renewed investor interest. Investors now require founders to retain equity and stay involved post-acquisition. With 90%+ of behavioral health still independently owned, consolidators see significant runway — if they can navigate Medicaid uncertainty from the One Big Beautiful Bill Act and exchange subsidy changes. Analysis from Lee Equity Partners, Mertz Taggart, and Beacon Behavioral Partners.

Why It Matters

For consolidators, fragmentation plus depressed SUD valuations equals entry opportunity — but the new deal structures demand founders stay in with rolled equity for three to five years. Sellers should price that into exit planning now.

behavioral health M&A SUD treatment PE consolidation rollover equity platform deals Medicaid uncertainty

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

Why is substance use disorder treatment called undervalued in 2026?

SUD deal flow sits at a six-year low — 33 addiction treatment deals closed last year, just seven in the final quarter — yet clinically strong operators are attracting renewed investor interest, per analysis from Lee Equity Partners, Mertz Taggart, and Beacon Behavioral Partners.

How fragmented is the behavioral health market?

More than 90% of behavioral health remains owned by independent operators or nonprofits, giving private equity groups and family offices a long consolidation runway through platform acquisitions.

What do behavioral health buyers now expect from sellers?

Founders are expected to roll equity and stay committed to the business for three to five years post-acquisition — a significant shift from earlier cash-out structures — while navigating Medicaid uncertainty from the One Big Beautiful Bill Act and exchange subsidy changes.

M&A / Growth Strategy

Dental M&A Rebounds: 175 Practices Sold in H1 2026 as Valuations Head Lower
Bypaulgruensfelder July 28, 2026

Dental practice M&A activity rebounded in the first half of 2026, with at least 175 practice locations sold to DSOs, private equity groups, and other buyers, according to TUSK Practice Sales, a figure the firm says likely undercounts actual volume due to reporting lag. Current valuations range from 5x to more than 9x EBITDA, but TUSK expects multiples to compress toward 4x-6x as dentistry matures into a more consolidated industry, with DSOs still structuring 60% to 85%+ of deal consideration in cash at closing. ADA data show 16.1% of U.S. dentists were DSO-affiliated in 2024.

Read More Dental M&A Rebounds: 175 Practices Sold in H1 2026 as Valuations Head Lower
Marketing

Patients Choose the Hospital Brand First: 53% Pick a System Before a Doctor
Bypaulgruensfelder July 27, 2026

When patients face a new health issue, a majority now choose the hospital or system first: 53% select a hospital first or pick a hospital and physician simultaneously, according to a July 2026 U.S. News & World Report survey of 500 U.S. adults who arranged care in the past 24 months. Hospital brand loyalty runs deep enough that 20% would switch providers to receive care at their preferred hospital. U.S. News attributes the pull to perceived safety, technology, and coordinated care across a trusted system. The data lands as U.S. News prepares its 37th Best Hospitals rankings (Aug. 4, 2026), adding new state and metro specialty rankings.

Read More Patients Choose the Hospital Brand First: 53% Pick a System Before a Doctor
M&A / Growth Strategy

Healthcare M&A Trends Q2 2026: PPM, Outpatient, and PE Scrutiny
Bypaulgruensfelder July 26, 2026

Healthcare M&A stayed steady in Q2 2026, driven by consolidation, AI integration, and cross-sector deals despite intensifying scrutiny of PE-backed MSO arrangements. Physician practice management remained active, with enablement platforms like Privia Health offering an alternative to full-ownership roll-ups. Ascension closed its AMSURG acquisition to become the third-largest ambulatory surgery center platform. For-profit systems kept divesting non-core assets—CHS sold Crestwood Medical Center for $459 million and four Arkansas hospitals to Freeman Health, part of a $1.2 billion, nine-hospital divestiture plan. Home health, hospice, and behavioral health saw continued PE-backed roll-ups, while digital health and health IT capital concentrated around scaled, high-performing platforms amid tariff-driven volatility and antitrust pressure.

Read More Healthcare M&A Trends Q2 2026: PPM, Outpatient, and PE Scrutiny
Operations

Commure Targets the 35–50% of Referrals That Never Convert
Bypaulgruensfelder July 26, 2026

Between 35% and 50% of medical referrals never result in a completed specialist appointment, and those that do take 31 days on average — a gap Commure’s new Orchestrator platform aims to close by automating end-to-end referral management and patient intake. The AI platform replaces fax-based referral workflows, targets referral leakage, and cuts pre-visit administrative work such as authorization holds and manual hand-offs. Commure frames the economics plainly: every unconverted referral is both a patient lost to follow-up and revenue that never shows up on the books. The launch adds to a fast-growing category of AI tools aimed at the pre-visit workflow, where leakage and intake friction remain among the most measurable revenue drains for multi-site provider groups.

Read More Commure Targets the 35–50% of Referrals That Never Convert
M&A / Growth Strategy

Select Medical Goes Private in $3.9B Welsh Carson-Led Deal
Bypaulgruensfelder July 26, 2026

Select Medical Holdings completed a $3.9 billion take-private on July 1, 2026, led by its founders and private equity firm Welsh, Carson, Anderson & Stowe at $16.50 per share — an 18% premium to its pre-announcement close. The Mechanicsburg, Pa. operator runs outpatient physical therapy (including NovaCare) across roughly 1,850 locations in 36 states, plus 104 long-term acute-care hospitals and 38 rehabilitation hospitals, with more than 45,000 employees and $5.5 billion in 2025 revenue. Management rolled equity alongside the sponsor, keeping operating leadership invested through the next value-creation cycle in post-acute and outpatient rehab.

Read More Select Medical Goes Private in $3.9B Welsh Carson-Led Deal
Marketing

Allina Health to Pay $12.5M to Settle Website Pixel Litigation
Bypaulgruensfelder July 24, 2026

Allina Health System agreed to pay $12.5 million to resolve a consolidated class action over its use of website tracking pixels, one of the larger settlements in the ongoing healthcare pixel litigation wave. Plaintiffs alleged the tools disclosed personally identifiable information and protected health information to third parties including Meta and Google, in violation of the Electronic Communications Privacy Act, the Minnesota Health Records Act, and state deceptive trade practices law. Allina denies wrongdoing. The fund splits into $10.3 million for patient portal, bill-pay, and scheduling users and $2.2 million for other patients, covering activity from September 2018 through May 2026.

Read More Allina Health to Pay $12.5M to Settle Website Pixel Litigation

Similar Posts